At Infinity Communications, we believe that good ideas know no limits. Whether you’re non-profit, biotech, MedTech or pharma, we’re here to help you create breakthrough communications for a healthier world.
Strategy
Storytelling
Engagement
Health communications with infinite impact
Who we are
Working side by side with your organisation, we bring passion, ingenuity and academic rigour to every project—creating clarity from complexity and producing meaningful content that leaves a lasting impression.
Meet the team
Geneva-based with an international reach, our team brings a unique blend of cross-sector experience that speaks to every audience – from patients and healthcare professionals to policy makers and global health actors.
Bespoke solutions
Our meticulous approach to research, planning and execution adds value to all our assignments regardless of sector, brand, growth stage or audience.
We help our clients thrive by delivering high-quality, targeted health communications on time and on budget.
We listen.
We engage.
We plan.
We create.
Bespoke solutions
Our meticulous approach to research, planning and execution adds value to all our assignments regardless of sector, brand, growth stage or audience.
We help our clients thrive by delivering high-quality, targeted health communications on time and on budget.
We listen.
We plan.
We create.
We engage.
Pharmaceuticals
Start-ups
Medical devices
NGOs & international organisations
Our expertise
At Infinity, we combine deep sector knowledge with strategic communication skills to help organisations in healthcare and global health make a lasting impact.
Our multidisciplinary expertise spans the following areas:
Our expertise
Therapeutic
Oncology, immunology, rheumatology, haematology, women’s health, respiratory, gut microbiome, diabetes, nutrition, rare diseases, Parkinson’s disease, multiple sclerosis, inflammatory diseases (originals and biosimilars), epigenetics, biogerontology, geroscience, medical devices and infectious diseases.
Our expertise
Global health
Diagnostics R&D and equitable access in low- and middle-income countries, antimicrobial resistance, nutrition and malnutrition, global COVID-19 response.








